Furthermore, understanding how PTF1A function is subverted during pancreatic cancer initiation, and whether its reactivation could suppress or reverse tumor development, may yield novel approaches to prevention and treatment. This evidence concerns the gene PTF1A and familial pancreatic carcinoma.